WA
LLY icon

Wambolt & Associates’s Eli Lilly LLY Stock Holding History

Wambolt & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$371K Buy
478
+13
+3% +$10.1K 0.12% 132
2025
Q1 		$374K Sell
465
-21
-4% -$17.5K 0.13% 127
2024
Q4 		$376K Sell
486
-1,330
-73% -$1.1M 0.12% 135
2024
Q3 		$1.61M Buy
1,816
+9
+0.5% +$8.09K 0.44% 72
2024
Q2 		$1.65M Hold
1,807
– – 0.48% 69
2024
Q1 		$1.37M Buy
1,807
+449
+33% +$320K 0.41% 76
2023
Q4 		$791K Sell
1,358
-154
-10% -$89.9K 0.26% 121
2023
Q3 		$814K Buy
1,512
+137
+10% +$70.6K 0.3% 120
2023
Q2 		$645K Buy
1,375
+25
+2% +$10.5K 0.23% 138
2023
Q1 		$473K Hold
1,350
– – 0.17% 169
2022
Q4 		$494K Buy
1,350
+143
+12% +$50.7K 0.19% 151
2022
Q3 		$390K Sell
1,207
-50
-4% -$15.8K 0.17% 163
2022
Q2 		$407K Sell
1,257
-3
-0.2% -$901 0.16% 166
2022
Q1 		$369K Buy
1,260
+91
+8% +$23.4K 0.13% 176
2021
Q4 		$323K Buy
1,169
+3
+0.3% +$761 0.12% 196
2021
Q3 		$268K Hold
1,166
– – 0.11% 206
2021
Q2 		$269K Buy
+1,166
New +$234K 0.11% 209

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wambolt & Associates's LLY Position: Q2 2025 in Review

Wambolt & Associates increased its Eli Lilly (LLY) stake by 2.8% in Q2 2025, buying an estimated $10.1K and bringing the position to 478 shares worth $371K. The position accounts for 0.12% of the portfolio, ranked #132.

Wambolt & Associates first reported a position in LLY in Q2 2021 and has held it in 17 quarters since. The position peaked at $1.65M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Wambolt & Associates held 478 shares of Eli Lilly worth $371K as of Q2 2025.
  • Wambolt & Associates bought 13 Eli Lilly shares in Q2 2025, an estimated $10.1K.
  • Eli Lilly made up 0.12% of Wambolt & Associates's portfolio in Q2 2025, its #132 holding.
  • Wambolt & Associates first reported a position in Eli Lilly in Q2 2021 and has held it in 17 quarters since.
  • Wambolt & Associates's Eli Lilly position peaked at $1.65M in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Wambolt & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.